Let’s talk heavy periods. Always and The Fibroid Foundation partner to tackle menstrual health challenges.
Partnership advances awareness around heavy menstrual bleeding, alongside the introduction of Always’ Maxi Size 6.
March 5, 2026 – Always and The Fibroid Foundation are coming together ahead of International Women’s Day (March 8) to build awareness of the pressing issue of heavy menstrual bleeding—a condition that affects millions of women across the U.S. This announcement reflects a sponsored partnership focused on empowering women through education and awareness, and coincides with the introduction of the new Always Maxi Size 6 pad for heavy menstrual flow.
According to a national medical study, uterine fibroids, benign tumors that grow in or on the uterus, impact an estimated 70-80% of women by age 50 and are a leading cause of heavy menstrual bleeding. Many women report that fibroids significantly disrupt their daily lives, including excessive uterine bleeding that can lead to anemia, urinary problems, pelvic pressure and pain, sexual dysfunction, and infertility, all of which can affect quality of life.
“Our research showed that heavy menstrual bleeding can significantly disrupt routines and overall well-being, diminishing a woman’s quality of life,” said Alexzandra Spatholt, Lead Scientist at Always. “This crucial insight informed and inspired the development of Always’ newest and largest Maxi, Size 6. The design provides women our most absorbent maxi pad with new leak-guard cuffs for clot defense. We’re excited to share this with women experiencing heavy flow, empowering her to live life more confidently.”
For Sateria Venable, Founder of The Fibroid Foundation and a woman profoundly affected by uterine fibroids, the collaboration represents a meaningful step forward in bringing long-overdue attention to heavy menstrual bleeding.
“Every woman living with fibroids and heavy menstrual bleeding has a story that deserves to be heard,” said Venable. “We’re excited to work together with Always to shine a brighter light on an issue that affects millions of women, to amplify The Fibroid Foundation’s education and awareness efforts, and to help women seek the information and care they need to better manage their symptoms.”
